NASDAQ : AGPU

Axe Compute Inc. — Company profile

Technology · Software - Infrastructure · United States

Last price 8 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 92.73M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

Axe Compute Inc. provides access to graphics processing unit and digital asset treasury strategy. The company operates through two segments: Compute Services and Treasury Management; and Drug Discovery Services. The Compute Services and Treasury Management segment provides access to graphics processing unit compute capacity and digital asset treasury strategy focused on Aethir token. The Drug Discovery Services segment engages in the application of AI using its proprietary biobank of 150,000+ tumor samples, as well as creation of proprietary 3D culture models used in drug development. In addition, the company provides AI infrastructure cluster. The company was formerly known as Predictive Oncology Inc. and changed its name to Axe Compute Inc. in December 2025. Axe Compute Inc. was incorporated in 2002 and is based in Pittsburgh, Pennsylvania.

Details

NameAxe Compute Inc.
SectorTechnology
IndustrySoftware - Infrastructure
Employees14
Founded2002
CeoChristopher Miglino
CountryUnited States
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
IsinUS74039M4087
Cusip74039M408
Cik0001446159
Stock TypeCommon Stock

Key executives

NameTitle
Christopher MiglinoChief Executive Officer and Director
Kyle OkamotoPresident
Jeremy Yaukey-WitterChief Financial Officer
Erin McMahonVice President of Marketing and Investor Relations
Sara Turken J.D.General Counsel
Dr. Lawrence J. DeLucas D.Sc, O.D, Ph.D.Senior Vice President of Biologics
Dr. Arlette H. Uihlein FCAP, M.D.Senior Vice President of Translational Medicine and Drug Discovery and Medical Director

Contact

Address91 43rd Street, Suite 110, Pittsburgh, Pennsylvania 15201, United States
Phone412 432 1500
Websitehttps://axecompute.com